Teva Pharmaceuticals
TEVA
TEVA
646 hedge funds and large institutions have $20.1B invested in Teva Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 95 funds opening new positions, 232 increasing their positions, 196 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.1% less ownership
Funds ownership: 59.91% → 57.81% (-2.1%)
6% less capital invested
Capital invested by funds: $21.4B → $20.1B (-$1.31B)
34% less funds holding in top 10
Funds holding in top 10: 38 → 25 (-13)
Holders
646
Holding in Top 10
25
Calls
$703M
Puts
$416M
Top Buyers
| 1 | +$863M | |
| 2 | +$220M | |
| 3 | +$208M | |
| 4 |
JP Morgan Chase
New York
|
+$179M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$132M |
Top Sellers
| 1 | -$324M | |
| 2 | -$196M | |
| 3 | -$124M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$116M |
| 5 |
DFO
Duquesne Family Office
New York
|
-$113M |
